Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial

Clinical trial NCT07034703 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07034703
Sponsor: University Hospital, Rouen
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Resectable Pancreatic Duct Adenocarcinoma

Start date: 2025-09-01
Primary completion: 2030-09-01
Enrollment: 820

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.